Legacy Financial Advisors Inc. Has $879,000 Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Legacy Financial Advisors Inc. lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.4% during the second quarter, Holdings Channel.com reports. The firm owned 1,976 shares of the medical equipment provider’s stock after purchasing an additional 101 shares during the period. Legacy Financial Advisors Inc.’s holdings in Intuitive Surgical were worth $879,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of ISRG. Creekmur Asset Management LLC raised its holdings in Intuitive Surgical by 200.0% during the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 42 shares during the last quarter. Ridgewood Investments LLC acquired a new stake in shares of Intuitive Surgical in the 2nd quarter worth about $26,000. Able Wealth Management LLC bought a new position in Intuitive Surgical in the 4th quarter valued at about $28,000. Delos Wealth Advisors LLC boosted its stake in Intuitive Surgical by 380.0% during the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 57 shares during the last quarter. Finally, LRI Investments LLC bought a new stake in Intuitive Surgical during the 1st quarter worth approximately $30,000. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $486.20 on Friday. Intuitive Surgical, Inc. has a 1-year low of $254.85 and a 1-year high of $496.18. The business has a 50 day moving average of $468.01 and a 200 day moving average of $424.86. The company has a market capitalization of $172.46 billion, a price-to-earnings ratio of 87.76, a PEG ratio of 5.41 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.24. The business had revenue of $2.01 billion during the quarter, compared to analyst estimates of $1.97 billion. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The company’s revenue was up 14.5% on a year-over-year basis. During the same period in the prior year, the business posted $1.18 earnings per share. As a group, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 5.22 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on ISRG shares. Robert W. Baird increased their price target on Intuitive Surgical from $487.00 to $503.00 and gave the company an “outperform” rating in a research report on Friday, July 19th. Barclays raised their price target on shares of Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a research report on Thursday, July 18th. BTIG Research boosted their price target on shares of Intuitive Surgical from $469.00 to $494.00 and gave the stock a “buy” rating in a report on Wednesday, August 28th. Piper Sandler increased their price objective on shares of Intuitive Surgical from $490.00 to $495.00 and gave the company an “overweight” rating in a research note on Friday, July 19th. Finally, JPMorgan Chase & Co. upped their target price on Intuitive Surgical from $475.00 to $495.00 and gave the company an “overweight” rating in a report on Friday, July 19th. Six equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $446.45.

Insider Buying and Selling

In other Intuitive Surgical news, Director Amy L. Ladd sold 450 shares of the business’s stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $490.28, for a total value of $220,626.00. Following the completion of the sale, the director now owns 821 shares in the company, valued at $402,519.88. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, EVP Myriam Curet sold 2,818 shares of the firm’s stock in a transaction dated Tuesday, July 23rd. The stock was sold at an average price of $458.13, for a total value of $1,291,010.34. Following the sale, the executive vice president now directly owns 298 shares of the company’s stock, valued at $136,522.74. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Amy L. Ladd sold 450 shares of the stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $490.28, for a total value of $220,626.00. Following the completion of the sale, the director now owns 821 shares of the company’s stock, valued at approximately $402,519.88. The disclosure for this sale can be found here. Insiders have sold a total of 53,120 shares of company stock worth $25,528,753 in the last ninety days. 0.90% of the stock is owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.